Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases.
Lee
Francis Young-In
FY
Department of Orthopaedic Surgery, Children's Hospital of New York, Columbia University, New York, NY, USA. fl127@columbia.edu
Sinicropi
Stefano M
SM
Lee
Fred Suin
FS
Vitale
Michael G
MG
Roye
David P
DP
Choi
In Ho
IH
D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005593:Fracture Fixation, Internal; D017102:Fracture Healing; D006801:Humans; D007223:Infant; D008297:Male; D011446:Prospective Studies; D011542:Pseudarthrosis / Q000151:congenital* / Q000000981:diagnostic imaging / Q000628:therapy*; D011859:Radiography; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013978:Tibial Fractures / Q000151:congenital* / Q000000981:diagnostic imaging / Q000628:therapy*; D016212:Transforming Growth Factor beta / Q000627:therapeutic use*; D016896:Treatment Outcome
C525819:BMP7 protein, human; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta